Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications
Schematic representation of the TGF-β signaling pathway. TGFB exerts its action by forming dimers that bind to two copies of type II receptors (TGFBR-II) and two copies of type I receptors (TGFBR-I). Upon binding, TGFBR-I receptors are phosphorylated and activated by TGFBR-II receptors. The activated TGFBR-I receptors then phosphorylate the cytoplasmic transcription factors Smad2 and Smad3, which combine with Smad4 to form a trimer. This resultant complex translocates to the nucleus and regulates target gene expression.
Publication
Progress in Regenerative Medicine: Exploring Autologous Platelet Concentrates and Their Clinical Applications. (2023) Laura Giannotti, et al. Genes (Basel). 2023 Sep;14(9):1669. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TGF-B | TGFB | ncbigene_synonym | TGFB1 | 7040 |
| Homo sapiens | Primates | TGF-B | TGFB | famplex_relations | TGFB2 | 7042 |
| Homo sapiens | Primates | TGF-B | TGFB | famplex_relations | TGFB3 | 7043 |
| Homo sapiens | Primates | TGFBR-II | TGFBRII | ncbigene_synonym | TGFBR2 | 7048 |
| Homo sapiens | Primates | Smad4 | SMAD4 | ncbigene_symbol | SMAD4 | 4089 |
| Homo sapiens | Primates | Smad3 | SMAD3 | ncbigene_symbol | SMAD3 | 4088 |
| Homo sapiens | Primates | Smad2 | SMAD2 | ncbigene_symbol | SMAD2 | 4087 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|